menu
    • menu
    [{"orgOrder":0,"company":"Bio Elpida","sponsor":"Biovaxys","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Vaccine","year":"2021","type":"Agreement","leadProduct":"BVX-0918A","moa":"","graph1":"Oncology","graph2":"Preclinical","graph3":"Bio Elpida","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Bio Elpida \/ BioVaxys","highestDevelopmentStatusID":"4","companyTruncated":"Bio Elpida \/ BioVaxys"},{"orgOrder":0,"company":"Bio Elpida","sponsor":"Biovaxys","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Vaccine","year":"2021","type":"Partnership","leadProduct":"BVX-0918A","moa":"","graph1":"Oncology","graph2":"Preclinical","graph3":"Bio Elpida","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"Bio Elpida \/ BioVaxys Technology","highestDevelopmentStatusID":"4","companyTruncated":"Bio Elpida \/ BioVaxys Technology"},{"orgOrder":0,"company":"Bio Elpida","sponsor":"Biovaxys","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"","productType":"Vaccine","year":"2022","type":"Not Applicable","leadProduct":"BVX-0918","moa":"","graph1":"Oncology","graph2":"IND Enabling","graph3":"Bio Elpida","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Injectable\/Injection","sponsorNew":"Bio Elpida \/ BioVaxys Technology Corp","highestDevelopmentStatusID":"5","companyTruncated":"Bio Elpida \/ BioVaxys Technology Corp"}]

    Find Clinical Drug Pipeline Developments & Deals by Bio Elpida

    Menu

    Bio Elpida

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : BVX-0918

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Biovaxys

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

                            Details : BVX-0918A, BioVaxys’s cancer vaccines are created by extracting a patient’s own cancer cells, chemically treating them with a hapten, and re-injecting them into the patient to induce an immune response to proteins which are otherwise not immunogenic.

                            Brand Name : BVX-0918

                            Molecule Type : Vaccine

                            Upfront Cash : Not Applicable

                            June 08, 2022

                            Lead Product(s) : BVX-0918

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Biovaxys

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : BVX-0918A

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Biovaxys

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone

                            Details : Bio Elpida has completed the technology process transfer of BVX-0918A with BioVaxys and started the development phase using a Quality by Design (“QbD”) approach which includes establishing the control methods and manufacturing process development.

                            Brand Name : BVX-0918A

                            Molecule Type : Vaccine

                            Upfront Cash : Undisclosed

                            September 17, 2021

                            Lead Product(s) : BVX-0918A

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Biovaxys

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed

                            Bio Elpida

                            France arrow
                            The Pharmacy Technology
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : BVX-0918A

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Biovaxys

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            BioVaxys and BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction

                            Details : BioVaxys has signed the definitive exclusive bioproduction agreement with BioElpida, to begin the clinical-grade bioproduction and aseptic packaging for BXV-0918A, BioVaxys’ vaccine candidate for Stage III/Stage IV ovarian cancer.

                            Brand Name : BVX-0918A

                            Molecule Type : Vaccine

                            Upfront Cash : Undisclosed

                            May 03, 2021

                            Lead Product(s) : BVX-0918A

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Biovaxys

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth